Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $114,582,297,872
Number of Records: 1,245
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,347,662,77087
Pfizer$10,948,338,54997
Merck$10,710,366,83188
Teva Pharmaceutical Industries$10,118,294,92994
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,509,236,65180
Takeda Pharmaceutical$3,987,516,44732
Endo International$2,847,090,66729
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent Parent sort icon . Primary Offense TypeYearAgencyPenalty Amount
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.Endo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Endo Health Solutions and Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022CA-SFCA$10,000,000
Endo International plcEndo Internationaloff-label or unapproved promotion of medical products2022MULTI-AG$450,000,000
Endo Pharmaceuticals Inc.Endo Internationalprice-fixing or anti-competitive practices2018private lawsuit-federal$60,000,000
Endo Pharmaceuticals Inc.Endo Internationalprice-fixing or anti-competitive practices2018private lawsuit-federal$40,000,000
IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLANGilead Sciencesbenefit plan administrator violation2001EBSA$10,001
Gilead SciencesGilead SciencesFalse Claims Act and related2013LA-AG$250,000
Gilead Sciences, Inc.Gilead SciencesFalse Claims Act and related2020DOJ_CIVIL$97,000,000
GILEAD SCIENCESGilead Sciencesworkplace safety or health violation2000OSHA$5,700
GlaxoSmithKline LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
SB Pharmco Puerto Rico Inc.GlaxoSmithKlinedrug or medical equipment safety violation2010FDA$750,000,000
GlaxoSmithKline VaccinesGlaxoSmithKlineenvironmental violation2014EPA$172,900
GlaxoSmithKline LLCGlaxoSmithKlineenvironmental violation2014EPA$317,550
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2005DOJ_CIVIL$150,000,000
GlaxoSmithKline plcGlaxoSmithKlinekickbacks and bribery2016SEC$20,000,000
Block Drug Company IncorporatedGlaxoSmithKlinewage and hour violation2011WHD$352,773
SmithKline BeechamGlaxoSmithKlineFalse Claims Act and related2003DOJ_CIVIL$47,000,000
GLAXO SMITH KLINEGlaxoSmithKlineaviation safety violation2014FAA$59,500
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2003MULTI-AG$40,000,000
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2005MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2006GA-AG$418,952
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2012ID-AG$2,600,000
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2011KS-AG$4,250,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2010KY-AG$3,700,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2009KY-AG$661,860
GlaxoSmithKlineGlaxoSmithKlineFalse Claims Act and related2012LA-AG$10,000,000
GlaxoSmithKline LLCGlaxoSmithKlinedrug or medical equipment safety violation2012MULTI-AG$90,000,000
GlaxoSmithKline LLCGlaxoSmithKlineFalse Claims Act and related2010HI-AG$3,333,333
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2006MULTI-AG$70,000,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2006MULTI-AG$14,000,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2006MULTI-AG$3,500,000
GlaxoSmithKline, LLCGlaxoSmithKlinedrug or medical equipment safety violation2011MULTI-AG$40,750,000
GlaxoSmithKline, LLCGlaxoSmithKlinekickbacks and bribery2014MULTI-AG$105,000,000
SB Pharmco Puerto Rico Inc.GlaxoSmithKlinedrug or medical equipment safety violation2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $163,560,000
SmithKline Beecham Corp.GlaxoSmithKlineprice-fixing or anti-competitive practices2005MULTI-AG$10,000,000
SmithKline Beecham Corp.GlaxoSmithKlineFalse Claims Act and related2007TX-AG$1,400,000
GlaxoSmithKline LLCGlaxoSmithKlineFalse Claims Act and related2019IL-AG$54,653,931
GlaxoSmithKline Holdings (Americas)GlaxoSmithKlinetax violations2006IRS$3,400,000,000
GLAXOSMITHKLINE LLCGlaxoSmithKlineenvironmental violation2016PA-ENV$5,259
GlaxoSmithKline LLCGlaxoSmithKlineenvironmental violation2015NY-ENV$24,200
GlaxoSmithKline, LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2013MD-AG$15,000,000
GlaxoSmithKlineGlaxoSmithKlinedrug or medical equipment safety violation2010private lawsuit-federal$770,000,000
GlaxoSmithKlineGlaxoSmithKlinedrug or medical equipment safety violation2009private lawsuit-federal$28,000,000
GlaxoSmithKlineGlaxoSmithKlinedrug or medical equipment safety violation2008private lawsuit-federal$40,000,000
GlaxoSmithKlineGlaxoSmithKlinedrug or medical equipment safety violation2006private lawsuit-state$63,833,148
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2004private lawsuit-federal$175,000,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2005private lawsuit-federal$75,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2013private lawsuit-federal$35,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2011private lawsuit-federal$49,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2013private lawsuit-federal$150,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2013private lawsuit-federal$21,500,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2007private lawsuit-federal$70,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2004private lawsuit-federal$92,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2005private lawsuit-federal$100,000,000
GlaxoSmithKline PLCGlaxoSmithKlineprice-fixing or anti-competitive practices2005private lawsuit-federal$65,000,000
GlaxoSmithKlineGlaxoSmithKlineprice-fixing or anti-competitive practices2023IN-AG$1,270,000
GLAXOSMITHKLINE, LLCGlaxoSmithKlineenvironmental violation2014EPA(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550
GLAXOSMITHKLINE VACCINESGlaxoSmithKlineenvironmental violation2014EPA(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900
Glenmark Pharmaceuticals, Inc.Glenmark PharmaceuticalsHHS civil monetary penalties2015HHSOIG$2,887,300
Glenmark Generics Inc.Glenmark PharmaceuticalsFalse Claims Act and related2015TX-AG$13,750,000
Glenmark Pharmaceuticals Inc., USAGlenmark Pharmaceuticalsprice-fixing or anti-competitive practices2023DOJ_ANTITRUST$30,000,000
Glenmark PharmaceuticalsGlenmark Pharmaceuticalsprice-fixing or anti-competitive practices2023private lawsuit-federal$14,000,000
GNC Holdings Inc.Harbin Pharmaceutical Groupdrug or medical equipment safety violation2016FDA$2,250,000
General Nutrition CorporationHarbin Pharmaceutical Groupwage and hour violation2017MA-AG$72,304
General NutritionHarbin Pharmaceutical Groupwage and hour violation2016private lawsuit-federal$9,000,000
General NutritionHarbin Pharmaceutical Groupwage and hour violation2015private lawsuit-federal$350,014
General NutritionHarbin Pharmaceutical Groupwage and hour violation2007private lawsuit-federal$1,910,000
General NutritionHarbin Pharmaceutical Groupwage and hour violation2005private lawsuit-federal$60,000
General NutritionHarbin Pharmaceutical Groupwage and hour violation2005private lawsuit-state$4,600,000
General Nutrition Corp.Harbin Pharmaceutical Groupconsumer protection violation2002FL-AG$1,000,000
General Nutrition CorporationHarbin Pharmaceutical Groupemployment discrimination2019private lawsuit-federal$550,187
GNCHarbin Pharmaceutical Groupemployment discrimination2019NY-NYCCHR$35,000
General Nutrition Centers Inc.Harbin Pharmaceutical Groupconsumer protection violation2019private lawsuit-federal$6,000,000
GENERAL NUTRITION CORPORATIONHarbin Pharmaceutical Groupworkplace safety or health violation2019OSHA$7,674
GNC HOLDINGS LLCHarbin Pharmaceutical Groupworkplace safety or health violation2022OSHA$6,720
GNC HOLDINGS INC.Harbin Pharmaceutical Groupworkplace safety or health violation2023OSHA$17,858
Roxane Laboratories Inc.Hikma PharmaceuticalsFalse Claims Act and related2010DOJ_CIVIL$280,000,000
Boehringer Ingelheim Roxane, Inc.Hikma PharmaceuticalsFalse Claims Act and related2008MA-AG$1,800,000
Boehringer Ingelheim Roxane, Inc. et al.Hikma PharmaceuticalsFalse Claims Act and related2009IA-AG$357,000
Roxane Laboratories Inc.Hikma PharmaceuticalsFalse Claims Act and related2009OH-AG$2,400,000
Roxane Laboratories, Inc.Hikma PharmaceuticalsFalse Claims Act and related2009FL-AG$8,500,000
Roxane Laboratories, Inc.Hikma PharmaceuticalsFalse Claims Act and related2009IA-AG$357,000
Roxane, Inc.Hikma PharmaceuticalsFalse Claims Act and related2010MO-AG$3,100,000
Roxanne Laboratories and Boehringer IngelheimHikma PharmaceuticalsFalse Claims Act and related2008AL-AG$9,500,000
HIKMA PHARMACEUTICALSHikma Pharmaceuticalsworkplace safety or health violation2020OSHA$20,479
IDEXX Laboratories, Inc.IDEXX Laboratoriesemployment discrimination2020OFCCP$200,000
IDEXX Reference Laboratories, Inc.IDEXX Laboratoriesenvironmental violation2009AZ-DEQ$80,000
IDEXX DISTRIBUTION, INC.IDEXX Laboratoriesworkplace safety or health violation2017OSHA$9,600
IDEXX DISTRIBUTION, INC.IDEXX Laboratoriesworkplace safety or health violation2023OSHA$32,245
Incyte CorporationIncyte Corp.False Claims Act and related2021DOJ_CIVIL$12,600,000
Indivior SolutionsIndivior PLCFalse Claims Act and related2020DOJ_CIVIL$589,000,000
Indivior, Inc.Indivior PLCprice-fixing or anti-competitive practices2020FTC$10,000,000
Indivior plcIndivior PLCoff-label or unapproved promotion of medical products2021MULTI-AG$300,000,000
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2023MULTI-AG$102,500,000
Jazz Pharmaceuticals Inc.Jazz Pharmaceuticalsoff-label or unapproved promotion of medical products2007USAO$20,000,000
Jazz Pharmaceuticals plcJazz PharmaceuticalsFalse Claims Act and related2019DOJ_CIVIL$57,000,000
Advanced Sterilization Products, a division of Ethicon Inc.Johnson & Johnsondrug or medical equipment safety violation2013FDA$1,200,000
McNeil-PPC Inc.Johnson & Johnsondrug or medical equipment safety violation2015FDA$25,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.